Literature DB >> 22210784

Risk prediction in idiopathic pulmonary fibrosis.

Brett Ley, Harold R Collard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22210784     DOI： 10.1164/rccm.201111-1960ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Plasma proteins for risk prediction in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-06-15       Impact factor: 21.405

2.  Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Authors:  Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron
Journal:  Thorax       Date:  2014-09-12       Impact factor: 9.139

3.  Nurse-Led Palliative Care Clinical Trial Improves Knowledge and Preparedness in Caregivers of Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Kathleen Oare Lindell; Sara Jo Klein; Melinda S Veatch; Kevin F Gibson; Daniel J Kass; Mehdi Nouraie; Margaret Q Rosenzweig
Journal:  Ann Am Thorac Soc       Date:  2021-11

4.  Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis.

Authors:  Samuel Y Ash; Rola Harmouche; Diego Lassala Lopez Vallejo; Julian A Villalba; Kris Ostridge; River Gunville; Carolyn E Come; Jorge Onieva Onieva; James C Ross; Gary M Hunninghake; Souheil Y El-Chemaly; Tracy J Doyle; Pietro Nardelli; Gonzalo V Sanchez-Ferrero; Hilary J Goldberg; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Respir Res       Date:  2017-03-07

5.  Six-minute walk distance and survival time in patients with idiopathic pulmonary fibrosis in Brazil.

Authors:  Eliane Viana Mancuzo; Maria Raquel Soares; Carlos Alberto de Castro Pereira
Journal:  J Bras Pneumol       Date:  2018 Jul-Aug       Impact factor: 2.624

6.  Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.

Authors:  Kensaku Aihara; Tomohiro Handa; Toru Oga; Kizuku Watanabe; Kiminobu Tanizawa; Kohei Ikezoe; Yoshio Taguchi; Hiroe Sato; Kazuo Chin; Sonoko Nagai; Shuh Narumiya; Athol U Wells; Michiaki Mishima
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

7.  Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Carol Feghali-Bostwick; Carol M Artlett; Monika Gooz; Galina S Bogatkevich; Ilia Atanelishvili; Richard M Silver; Jeanette Wood; Victor J Thannickal; Suniti Misra
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.486

8.  Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.

Authors:  Sang Hoon Lee; Song Yee Kim; Dong Soon Kim; Young Whan Kim; Man Pyo Chung; Soo Taek Uh; Choon Sik Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jong Wook Shin; Eun Joo Lee; Jin Hwa Lee; Yangin Jegal; Hyun Kyung Lee; Yong Hyun Kim; Jin Woo Song; Sung Woo Park; Moo Suk Park
Journal:  Respir Res       Date:  2016-10-18

9.  Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.

Authors:  Yunguan Wang; Jaswanth Yella; Jing Chen; Francis X McCormack; Satish K Madala; Anil G Jegga
Journal:  BMC Pulm Med       Date:  2017-10-20       Impact factor: 3.317

10.  A score without diffusion capacity of the lung for carbon monoxide for estimating survival in idiopathic pulmonary fibrosis.

Authors:  Cesar Yoshito Fukuda; Maria Raquel Soares; Carlos Alberto de Castro Pereira
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.